Recent Company News

• 08:18 AM ET May 07, 2025
  

  StreetAccount Summary - US Pre-market trading

• 07:15 AM ET May 07, 2025
  

  Amarin Corp. reports Q1 EPS ($0.04) vs FactSet ($0.77) [2 est, ($0.80)-(0.74)] ($10.19, 0.00)

• 01:27 PM ET Apr 11, 2025
  

  StreetAccount Activist Summary: Week of 7-Apr

• 07:33 AM ET Apr 09, 2025
  

  Amarin confirms effective date for 1-for-20 ADS ratio change ($0.43, 0.00)

• 07:35 AM ET Apr 07, 2025
  

  Amarin Corp. announces appointment of JEC Partners' Michael Torok to board, effective immediately ($0.40, 0.00)

• 08:11 AM ET Mar 31, 2025
  

  Amarin highlights recent data presented at ACC.25 evaluating mechanistic effects of EPA in LP(a)-enriched plasma and in combination with GLP-1 agonist ($0.44, 0.00)

• 01:06 PM ET Mar 28, 2025
  

  StreetAccount Activist Summary: Week of 24-Mar

• 08:55 PM ET Mar 25, 2025
  

  Amarin Corp. board member Mark DiPaolo does not intend to stand for reelection to the Board - 13D/A

• 10:44 AM ET Mar 21, 2025
  

  StreetAccount Activist Summary: Week of 17-Mar

• 04:27 PM ET Mar 19, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market